Login
$CYRX
$19.80 -$0.09 (0.45%) Live

$CYRX 8-K/A SEC Filings

Filed On Filing
14 Dec 2020 8-K/A: Financial Statements and Exhibits

On October 1, 2020, Cryoport, Inc. (the “Company” or “Cryoport”) completed its acquisition of CRYOPDP for a cash consideration of €49 million, subject to cash, net debt, working capital and other adjustments (the “CRYOPDP Acquisition”). ...

08 May 2020 8-K/A: Results of Operations and Financial Condition

Revenue from commercial therapies increased 110% over the prior year

03 Mar 2020 8-K/A: Submission of Matters to a Vote of Security Holders

At the Annual Meeting, the Company’s stockholders voted on, among other matters, an advisory proposal (the “Say-on-Frequency Proposal”) concerning the frequency of future advisory votes on executive compensation. As reported in the Initi...

14 Jun 2019 8-K/A: Financial Statements and Exhibits

We have audited the accompanying balance sheets of CryoGene Partners (the “Company”), which comprise the balance sheets as of December 31, 2018 and 2017, and the related statements of income and partners’ capital, and cash flows for the ...

16 Aug 2016 8-K/A: Results of Operations and Financial Condition

Company added 28 new biopharma clients during first three months of FY2017 and is supporting 23 of 28 leading CAR-T projects

29 Feb 2008 8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
03 May 2007 8-K/A: Entry into a Material Definitive Agreement

On April 30, 2007, the Company mistakenly filed attachments to item 1.01 which were incomplete or incorrect. The corrected exhibits are attached hereto.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support